Clinical Trials Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jul 14, 2023; 29(26): 4200-4213
Published online Jul 14, 2023. doi: 10.3748/wjg.v29.i26.4200
Figure 2
Figure 2 Relationship between raf kinase inhibitor protein and phosphorylated-extracellular-signal regulated kinase co-expression and prognosis in gastrointestinal stromal tumors. Comparison with the raf kinase inhibitor protein (RKIP)-negative and phosphorylated-extracellular signal-regulated kinase (P-ERK)-positive groups; RKIP high expression group is correlated with a better survival rate and the difference was significant. Log-rank analysis, P = 0.0312.